Florida’s medical marijuana program generated $135,036,120 in November sales, bringing the year-to-date total to roughly $1.51 billion.
The new data provided by the research firm Headset underscores the strength of Florida’s medical cannabis indsutry, which is the largest medical-only market in the nation.
January set the early pace at about $145.6 million, and every subsequent month has landed somewhere between roughly $123.5 million and $155.5 million. While individual months have moved up and down within that range, the overall trend has been steady, with November’s $135.0 million keeping the year-to-date total firmly above the $1.5 billion mark.
Product categories show a clear favorite. Flower accounted for 46% of all spending through November, or just under $700 million in sales. Vaporizers and vape pens made up 23% of revenue, totaling roughly $350 million. Edibles and concentrates each represented about 11% of the market, at around $167 million apiece. Pre-rolls contributed 4% (about $61 million), tinctures 2% (about $30 million) and topicals about 0.5%, or roughly $7.5 million statewide.
According to the Florida Department of Health, the state has around 930,000 registered medical cannabis patients.
An effort to place an initiative to legalize recreational cannabis on the November 2026 ballot says they’ve collected over a million signatures, well more than the required amount.





